Lunit acquires Volpara Health Technologies to advance AI in cancer diagnostics
Lunit, a leader in AI-powered solutions for cancer diagnostics and therapeutics, has completed its acquisition of Volpara Health Technologies, a global frontrunner in medical software ... Read More
Lunit announces strategic partnerships to advance AI in cancer diagnostics across Europe
Lunit (KRX:328130.KQ), a frontrunner in AI-powered solutions for cancer diagnostics and therapeutics, is marking a significant milestone in its expansion across Europe through two pivotal ... Read More